The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound

Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

[search][options]

Editor

Personal info

View

About

Terms

Javascript disabled

Please enable Javascript support in your browser to use this application.

Instructions on how to enable JavaScript on different browsers can be found here: http://www.google.com/support/bin/answer.py?answer=23852.

Peter F. Bross

Division of Oncology Drug Products

Center for Drug Evaluation and Research

Food and Drug Administration

Rockville

USA

[email]@cder.fda.gov

Name/email consistency: high

[Claim this account]

Affiliation

Division of Oncology Drug Products, Center for Drug Evaluation and Research, Food and Drug Administration, Rockville, USA. 2001 - 2002

References

FDA drug approval summaries: fulvestrant. Bross, P.F., Cohen, M.H., Williams, G.A., Pazdur, R. Oncologist (2002) [Pubmed]
Approval summary: gemtuzumab ozogamicin in relapsed acute myeloid leukemia. Bross, P.F., Beitz, J., Chen, G., Chen, X.H., Duffy, E., Kieffer, L., Roy, S., Sridhara, R., Rahman, A., Williams, G., Pazdur, R. Clin. Cancer Res. (2001) [Pubmed]